Search hospitals > North Carolina > Statesville

Piedmont Healthcare

Claim this profile
Statesville, North Carolina 28625
Conducts research for Type 2 Diabetes
Conducts research for Crohn's Disease
Conducts research for Ulcerative Colitis
Conducts research for Cardiovascular Disease
Conducts research for Colitis
21 reported clinical trials
0 medical researchers
Photo of Piedmont Healthcare in StatesvillePhoto of Piedmont Healthcare in Statesville

Summary

Piedmont Healthcare is a medical facility located in Statesville, North Carolina. This center is recognized for care of Type 2 Diabetes, Crohn's Disease, Ulcerative Colitis, Cardiovascular Disease, Colitis and other specialties. Piedmont Healthcare is involved with conducting 21 clinical trials across 40 conditions. There are 0 research doctors associated with this hospital, such as .

Top PIs

Clinical Trials running at Piedmont Healthcare

Crohn's Disease
Ulcerative Colitis
Colitis
Heart Failure
Multiple Sclerosis
Asthma
Chronic Urticaria
Medical Device Site Urticaria
Image of trial facility.

Vedolizumab

for Ulcerative Colitis and Crohn's Disease

Ulcerative Colitis (UC) and Crohn's Disease (CD) are long-term conditions in the gut that can cause diarrhea, swelling (inflammation), bleeding from the anus, and belly pain. The main aim of this study is to check for how many participants with UC and CD signs and symptoms disappear after 3.5 months (14 weeks) of treatment with Vedolizumab (this is called remission). Participants will be treated with Vedolizumab for approximately 1 year (50 weeks). During the first 1.5 months (6 weeks), participants will receive Vedolizumab as an infusion in the vein (called intravenously). After this, participants will receive Vedolizumab as an injection under the skin (called subcutaneously) for the rest of the treatment. Participants for whom the treatment does not seem to work well after 3.5 months (14 weeks) will stop treatment with Vedolizumab and can change to another treatment and also there will be additional required visits at 6 months (26 weeks) and at 1 year (52 weeks). All participants will be checked again 4.5 months (18 weeks) after their last treatment with Vedolizumab. During the study, participants will visit their study clinic several times.
Recruiting3 awards Phase 42 criteria

Similar Hospitals nearby

Select from list below to view details

Frequently asked questions

What kind of research happens at Piedmont Healthcare?
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Terms of Service·Privacy Policy·Cookies·Security
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Terms of Service·Privacy Policy·Cookies·Security